摘要
背景:非酒精性脂肪肝(NAFLD)是最常见的慢性肝病,是引起隐匿性肝硬化的主要原因,并一直与相关的代谢性dis有关。顺序,如血脂异常和2型糖尿病(T2D)。然而,NAFLD的发病机制尚不清楚,目前还没有建立治疗NAFLD的治疗方案。腺苷单酚SPHOT(AMP)激活的蛋白激酶(AMPK)是细胞的主要能量传感器,被认为是肝脏脂质代谢和糖代谢的关键调节因子。最近,新的证据表明许多植物来源的天然产物能够通过靶向AMPK来改善NAFLD。 方法:对PubMed在2016年6月发表的相关文献进行检索。 结果:在了解植物源性天然产物对NAFLD的保护作用方面取得了重大进展。多种天然产物,包括生物碱(B)黄连素、去乙基小檗碱、尼古丁、咖啡因等,多酚(白藜芦醇、葛根素、姜黄素、咖啡酸等)和其他化合物(β-石竹烯、天麻素、化合物K、白桦碱)在临床前的研究中显示出了有希望的结果。这些化合物的机理研究集中在它们激活AMPK及其下游效应物参与脂质代谢。abolish废除,废止 结论:本研究结果证实植物源性天然产物能激活AMPK信号通路是治疗非酒精性脂肪肝的潜在药物。VVV
关键词: 非酒精性脂肪肝病,AMP激酶,天然产物,脂质代谢,生物碱,多酚,抗氧化,抗炎。
Current Medicinal Chemistry
Title:Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products
Volume: 25 Issue: 8
关键词: 非酒精性脂肪肝病,AMP激酶,天然产物,脂质代谢,生物碱,多酚,抗氧化,抗炎。
摘要: Background: Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, is the leading cause of cryptogenic cirrhosis and has consistently been implicated in related metabolic disorders, such as dyslipidemia and type 2 diabetes (T2D). However, the pathogenesis of NAFLD remains to be elucidated, and no established therapeutic regimens for treating NAFLD exist. Adenosine monophosphate (AMP)-activated protein kinase (AMPK), the main cellular energy sensor, has been implicated as a key regulator of hepatic lipid and glucose metabolism. Recently, emerging evidence indicates that many plant-derived natural products are capable of ameliorating NAFLD by targeting AMPK.
Methods: The published literature in PubMed relating to this topic was searched through June 2016.
Results: Significant advances have been made with respect to understanding the protective effects of plant-derived natural products against NAFLD. A variety of natural products, including alkaloids (berberine, demethyleneberberine, nicotine, caffeine, etc.), polyphenols (resveratrol, puerarin, curcumin, caffeic acid, etc.) and other compounds (β- caryophyllene, gastrodin, compound K, betulinic acid, etc.), have demonstrated promising results in preclinical studies. Mechanistic studies of these compounds have focused on their activation of AMPK and its downstream effectors involved in lipid metabolism.
Conclusion: The findings of this review confirm that plant-derived natural products capable of activating the AMPK signaling pathway are potential therapeutic agents for NAFLD.
Export Options
About this article
Cite this article as:
Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products, Current Medicinal Chemistry 2018; 25 (8) . https://dx.doi.org/10.2174/0929867324666170404142450
DOI https://dx.doi.org/10.2174/0929867324666170404142450 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Roles of miRNA in Cardiovascular Development and Dysfunction
Current Medicinal Chemistry Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Combinatorial Chemistry & High Throughput Screening Emerging Roles for Vasoactive Peptides in Diagnostic and Therapeutic Strategies Against Atherosclerotic Cardiovascular Diseases
Current Protein & Peptide Science Incretin Pharmacology: A Review of the Incretin Effect and Current Incretin-Based Therapies
Cardiovascular & Hematological Agents in Medicinal Chemistry Imaging and Laboratory Biomarkers in Cardiovascular Disease
Current Pharmaceutical Design Targeting Mitochondria for Cardiac Protection
Current Drug Targets Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
Current Pharmaceutical Design Transdermal Innovations in Diabetes Management
Current Diabetes Reviews Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design The Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase Signaling in Cardiovascular Therapy
Current Signal Transduction Therapy Influence of a High-Fat Diet on Cardiac iNOS in Female Rats
Current Vascular Pharmacology Blood Pressure Management in Metabolic Syndrome
Current Hypertension Reviews Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents
Current Pharmaceutical Design Editorial [Hot Topic:Translating Clinical Evidence into the Practice of Diabetes Care (Guest Editor: Richard W. Grant Contents)]
Current Diabetes Reviews Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Current Drug Targets Association Between the Levels of Circulating Adhesion Molecules and Biopterins in Type-2 Diabetic Normotensive Patients Adhesion Molecules and Biopterins
Endocrine, Metabolic & Immune Disorders - Drug Targets Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Ginger and Heart Health: From Mechanisms to Therapeutics
Current Molecular Pharmacology Pulmonary Hemorrhage in Patients with Systemic Lupus Erythematosus
Current Respiratory Medicine Reviews